Clinical Trial Update: Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) for Patients With Spinocerebellar Ataxia [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update for Umbilical Cord Mesenchymal Stem Cells Therapy (19#iSCLife®-SA) in spinocerebellar ataxia, with status not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Spinocerebellar Ataxia Type

Drugs mentioned

• 19#iSCLife®-SA

Snippet

Sponsor: Sclnow Biotechnology Co., Ltd. | Conditions: Spinocerebellar Ataxia Type 1, Spinocerebellar Ataxia Type 2 | Phase 2 | Status: NOT_YET_RECRUITING